pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Aug 17·1 min read
save

Becton Dickinson recalls intraosseous needle sets over risk of obturator removal difficulty

Aug 17, 2026·read at fda medwatch ↗CRLNegative

Becton Dickinson has issued a recall for specific intraosseous vascular access system needle sets after discovering that the obturator (stylet) can be difficult to remove once the device is placed.

The recall covers several needle kits used with powered drivers, ranging from 15mm to 55mm in length and identified by catalog numbers D015151NK, D015251NK, D015351NK, D015451NK, and D015551NK, each with corresponding UDI numbers.

Customers who received a notice on July 30, 2026 are instructed to stop using the affected lots immediately, locate any inventory, and destroy the kits according to their facility’s procedures. If immediate destruction is not possible, the products should be quarantined until they can be safely disposed of.

The FDA has classified this as a Class I recall, the most serious category, because continued use could lead to severe injury or death.

source

This writeup was produced by pharmadog from original reporting by fda medwatch.

Original headline: “Intraosseous Needle Set Recall: Becton Dickinson Removes Certain Intraosseous Vascular Access System Needle Sets”

read at fda medwatch ↗
843 words · retrieved Aug 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BECTON DICKINSON3BECTON DICKINSON CO3EMERGENTUNIQUE
topics
Recall11

related stories

  • Aug 4Early Alert: Intraosseous Needle Set Issue from Becton Dickinsonfda medwatch
  • Sep 24Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampulesfda medwatch
  • Aug 18Early Alert: Convenience Kit Issue from Becton Dickinsonfda medwatch
  • Jul 16Convenience Kit Correction: Arrow International Issues Correction for Convenience Kits Containing Recalled Huons Lidocaine and Bupivacaine and Salinefda medwatch
  • Aug 10FDA issues alert in wake of BD recall of faulty needle setsFierce Biotech